Planethowells, I'm talking about NV-128 which is an analogue of phenoxodiol. From what I have read NV-128 looks will take over from Novogen's prio Ovarian treatment, but not directly as it can be used against other cancers. I think I'd need a solid week or two to reach a conclusion - hence the uncertainty in my posts on this thread.
http://www.yale.edu/opa/arc-ybc/v36.n27/story7.html.
Intersting that the Novegen website doesn't mention this in their oncology program description.
http://novogen.com.au/pharma/pharma0401.cfm?mainsection=04&subsection=03 (NV-128 section explains it is an anolog of Ovature / phenoxodiol).
thank the lord we will now be saved, page-7
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.5¢ | 29.0¢ | $1.805M | 5.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 193400 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |